The economic viability of suzetrigine also has become a subject of debate. The Institute for Clinical and Economic Critique, a nonprofit Corporation that evaluates prescription drug Value-effectiveness, has instructed that the drug could be only marginally more Expense-efficient than opioids if priced at about $420 every week.Suggest both clients a